Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, 790-8577, Japan.
Division of Cell Signaling, Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, 770-8503, Japan.
Nat Commun. 2022 Jan 10;13(1):183. doi: 10.1038/s41467-021-27818-z.
Proteolysis-targeting chimaeras (PROTACs) as well as molecular glues such as immunomodulatory drugs (IMiDs) and indisulam are drugs that induce interactions between substrate proteins and an E3 ubiquitin ligases for targeted protein degradation. Here, we develop a workflow based on proximity-dependent biotinylation by AirID to identify drug-induced neo-substrates of the E3 ligase cereblon (CRBN). Using AirID-CRBN, we detect IMiD-dependent biotinylation of CRBN neo-substrates in vitro and identify biotinylated peptides of well-known neo-substrates by mass spectrometry with high specificity and selectivity. Additional analyses reveal ZMYM2 and ZMYM2-FGFR1 fusion protein-responsible for the 8p11 syndrome involved in acute myeloid leukaemia-as CRBN neo-substrates. Furthermore, AirID-DCAF15 and AirID-CRBN biotinylate neo-substrates targeted by indisulam and PROTACs, respectively, suggesting that this approach has the potential to serve as a general strategy for characterizing drug-inducible protein-protein interactions in cells.
蛋白水解靶向嵌合体(PROTACs)以及分子胶,如免疫调节药物(IMiDs)和 indisulam,是诱导底物蛋白与 E3 泛素连接酶相互作用以实现靶向蛋白降解的药物。在这里,我们开发了一种基于 AirID 的邻近依赖性生物素化的工作流程,用于鉴定 E3 连接酶 cereblon(CRBN)的药物诱导的新底物。使用 AirID-CRBN,我们在体外检测到 IMiD 依赖性 CRBN 新底物的生物素化,并通过高特异性和选择性的质谱法鉴定出已知新底物的生物素化肽。进一步的分析表明,ZMYM2 和 ZMYM2-FGFR1 融合蛋白——急性髓系白血病中涉及 8p11 综合征的原因——是 CRBN 的新底物。此外,AirID-DCAF15 和 AirID-CRBN 分别生物素化 indisulam 和 PROTACs 靶向的新底物,这表明该方法有可能成为一种通用策略,用于表征细胞中药物诱导的蛋白质-蛋白质相互作用。